zepbound semaglutide or tirzepatide Zepbound: The newest obesity medication explained by an expert GLP-1 Updates: semaglutide / tirzepatide

This month pharmacies will no longer be allowed to sell lower-cost compounded versions of the anti-obesity drug tirzepatide and costs to consumers will triple, from $350 a month to $1,000.

Specifically, a machine-learning based attribution mapping of~68,250 posts related to GLP-1 or GLP-1/GIP agonists on the Reddit platform

Grapefruit juice can interfere with how certain medications work by affecting drug metabolism and absorption, leading to either increased side effects or reduced effectiveness

Verdin E

Start an application on behalf of your patient, for the Novo Nordisk Patient Assistance Program (PAP), and get answers to frequently asked questions about eligibility and enrollment.

Its a dual-action GLP-1/GIP that is approved by the FDA for people with obesity BMI 30, or overweight BMI 27 plus a weight-related condition, along with diet and exercise changes